93 related articles for article (PubMed ID: 12594173)
1. Glutaredoxin is essential for maintenance of brain mitochondrial complex I: studies with MPTP.
Kenchappa RS; Ravindranath V
FASEB J; 2003 Apr; 17(6):717-9. PubMed ID: 12594173
[TBL] [Abstract][Full Text] [Related]
2. Estrogen and neuroprotection: higher constitutive expression of glutaredoxin in female mice offers protection against MPTP-mediated neurodegeneration.
Kenchappa RS; Diwakar L; Annepu J; Ravindranath V
FASEB J; 2004 Jul; 18(10):1102-4. PubMed ID: 15132975
[TBL] [Abstract][Full Text] [Related]
3. Constitutive expression and functional characterization of mitochondrial glutaredoxin (Grx2) in mouse and human brain.
Karunakaran S; Saeed U; Ramakrishnan S; Koumar RC; Ravindranath V
Brain Res; 2007 Dec; 1185():8-17. PubMed ID: 17961515
[TBL] [Abstract][Full Text] [Related]
4. Thioltransferase (glutaredoxin) mediates recovery of motor neurons from excitotoxic mitochondrial injury.
Kenchappa RS; Diwakar L; Boyd MR; Ravindranath V
J Neurosci; 2002 Oct; 22(19):8402-10. PubMed ID: 12351714
[TBL] [Abstract][Full Text] [Related]
5. Downregulation of glutaredoxin but not glutathione loss leads to mitochondrial dysfunction in female mice CNS: implications in excitotoxicity.
Diwakar L; Kenchappa RS; Annepu J; Ravindranath V
Neurochem Int; 2007 Jul; 51(1):37-46. PubMed ID: 17512091
[TBL] [Abstract][Full Text] [Related]
6. Down-regulation of glutaredoxin by estrogen receptor antagonist renders female mice susceptible to excitatory amino acid mediated complex I inhibition in CNS.
Diwakar L; Kenchappa RS; Annepu J; Saeed U; Sujanitha R; Ravindranath V
Brain Res; 2006 Dec; 1125(1):176-84. PubMed ID: 17109834
[TBL] [Abstract][Full Text] [Related]
7. Deficiency of TNF receptors suppresses microglial activation and alters the susceptibility of brain regions to MPTP-induced neurotoxicity: role of TNF-alpha.
Sriram K; Matheson JM; Benkovic SA; Miller DB; Luster MI; O'Callaghan JP
FASEB J; 2006 Apr; 20(6):670-82. PubMed ID: 16581975
[TBL] [Abstract][Full Text] [Related]
8. 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced complex I inhibition is reversed by disulfide reductant, dithiothreitol in mouse brain.
Annepu J; Ravindranath V
Neurosci Lett; 2000 Aug; 289(3):209-12. PubMed ID: 10961666
[TBL] [Abstract][Full Text] [Related]
9. Selective alterations of gene expression in mice induced by MPTP.
Xu Z; Cawthon D; McCastlain KA; Slikker W; Ali SF
Synapse; 2005 Jan; 55(1):45-51. PubMed ID: 15499605
[TBL] [Abstract][Full Text] [Related]
10. Comparison of the time courses of selective gene expression and dopaminergic depletion induced by MPP+ in MN9D cells.
Wang J; Duhart HM; Xu Z; Patterson TA; Newport GD; Ali SF
Neurochem Int; 2008 May; 52(6):1037-43. PubMed ID: 18069091
[TBL] [Abstract][Full Text] [Related]
11. Neuroprotective effect of vasoactive intestinal peptide (VIP) in a mouse model of Parkinson's disease by blocking microglial activation.
Delgado M; Ganea D
FASEB J; 2003 May; 17(8):944-6. PubMed ID: 12626429
[TBL] [Abstract][Full Text] [Related]
12. Cyclooxygenases mRNA and protein expression in striata in the experimental mouse model of Parkinson's disease induced by 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine administration to mouse.
Przybyłkowski A; Kurkowska-Jastrzebska I; Joniec I; Ciesielska A; Członkowska A; Członkowski A
Brain Res; 2004 Sep; 1019(1-2):144-51. PubMed ID: 15306248
[TBL] [Abstract][Full Text] [Related]
13. Changes in cytoskeletal gene expression linked to MPTP-treatment in Mice.
Cuadrado-Tejedor M; Sesma MT; Giménez-Amaya JM; Ortiz L
Neurobiol Dis; 2005 Dec; 20(3):666-72. PubMed ID: 16005240
[TBL] [Abstract][Full Text] [Related]
14. Adenovirus-mediated transduction with human glial cell line-derived neurotrophic factor gene prevents 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced dopamine depletion in striatum of mouse brain.
Kojima H; Abiru Y; Sakajiri K; Watabe K; Ohishi N; Takamori M; Hatanaka H; Yagi K
Biochem Biophys Res Commun; 1997 Sep; 238(2):569-73. PubMed ID: 9299553
[TBL] [Abstract][Full Text] [Related]
15. Reaction mechanism and regulation of mammalian thioredoxin/glutathione reductase.
Sun QA; Su D; Novoselov SV; Carlson BA; Hatfield DL; Gladyshev VN
Biochemistry; 2005 Nov; 44(44):14528-37. PubMed ID: 16262253
[TBL] [Abstract][Full Text] [Related]
16. Effects of blocking the dopamine biosynthesis and of neurotoxic dopamine depletion with 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) on voluntary wheel running in mice.
Leng A; Mura A; Hengerer B; Feldon J; Ferger B
Behav Brain Res; 2004 Oct; 154(2):375-83. PubMed ID: 15313025
[TBL] [Abstract][Full Text] [Related]
17. Activation of p38 MAPK in the substantia nigra leads to nuclear translocation of NF-kappaB in MPTP-treated mice: implication in Parkinson's disease.
Karunakaran S; Ravindranath V
J Neurochem; 2009 Jun; 109(6):1791-9. PubMed ID: 19457134
[TBL] [Abstract][Full Text] [Related]
18. H MRS identifies lactate rise in the striatum of MPTP-treated C57BL/6 mice.
Koga K; Mori A; Ohashi S; Kurihara N; Kitagawa H; Ishikawa M; Mitsumoto Y; Nakai M
Eur J Neurosci; 2006 Feb; 23(4):1077-81. PubMed ID: 16519673
[TBL] [Abstract][Full Text] [Related]
19. Upregulation of guanylyl cyclase expression and activity in striatum of MPTP-induced parkinsonism in mice.
Chalimoniuk M; Langfort J; Lukacova N; Marsala J
Biochem Biophys Res Commun; 2004 Nov; 324(1):118-26. PubMed ID: 15464991
[TBL] [Abstract][Full Text] [Related]
20. Nicotine and caffeine-mediated modulation in the expression of toxicant responsive genes and vesicular monoamine transporter-2 in 1-methyl 4-phenyl-1,2,3,6-tetrahydropyridine-induced Parkinson's disease phenotype in mouse.
Singh S; Singh K; Patel S; Patel DK; Singh C; Nath C; Singh MP
Brain Res; 2008 May; 1207():193-206. PubMed ID: 18374908
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
